Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart Failure with Preserved Systolic Function.

Michael Domanski1, Eliot Peyster

  • 1The Clinical Trials Group, National Heart, Lung, and Blood Institute, 6701 Rockledge, Bethesda, MD 20892, USA. DomanskM@nhlbi.nih.gov.

Current Treatment Options in Cardiovascular Medicine
|May 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Junctophilin-2 abundance is unaltered in human heart failure samples with disrupted T-tubules and contractility.

Journal of molecular and cellular cardiology·2026
Same author

From the Bench to the Bedside and Back: Contemporary Applications of Basic Science to Innovations in Heart Transplantation.

The Canadian journal of cardiology·2025
Same author

Computational Pathology Assessments of Cardiac Stromal Remodeling: Clinical Correlates and Prognostic Implications in Heart Transplantation.

Research square·2024
Same author

Beyond the Granuloma: New Insights into Cardiac Sarcoidosis Using Spatial Proteomics.

Research square·2024
Same author

A heart transplant center experience with basiliximab induction strategies: A double edged sword?

Clinical transplantation·2024
Same author

The evolving use of biomarkers in heart transplantation: Consensus of an expert panel.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2023

Heart failure with preserved ejection fraction (HFpEF) affects 30% of patients, often older hypertensives. Diagnosis relies on heart failure symptoms, normal systolic function, and diastolic dysfunction evidence, frequently via tissue Doppler imaging.

Area of Science:

  • Cardiology
  • Heart Failure Research

Background:

  • Congestive heart failure (CHF) affects millions, with a significant subset presenting with preserved systolic function.
  • This population, often older and hypertensive, experiences hospitalization rates comparable to systolic dysfunction heart failure.
  • Mortality rates are intermediate, highlighting the clinical significance of this condition.

Purpose of the Study:

  • To delineate the characteristics and diagnostic criteria for heart failure with preserved systolic function (HFpEF).
  • To review current understanding of the pathophysiology and therapeutic strategies for HFpEF.

Main Methods:

  • Diagnosis requires confirmation of the heart failure syndrome with normal systolic function and no significant valvular disease.
  • Tissue Doppler imaging is a key diagnostic tool for identifying diastolic dysfunction.

Related Experiment Videos

  • Review of existing literature on treatment approaches.

    • Main Results:

    • HFpEF constitutes at least 30% of CHF cases, predominantly in older, hypertensive individuals.
    • Hospitalization rates are similar to systolic dysfunction heart failure, with intermediate mortality.
    • Diastolic dysfunction is the hallmark, often diagnosed using tissue Doppler imaging.

    Conclusions:

    • HFpEF is a distinct clinical entity requiring specific diagnostic approaches.
    • Acute management focuses on volume and heart rate control.
    • Long-term strategies should target underlying causes like hypertension and left ventricular hypertrophy, with promising avenues in renin-angiotensin-aldosterone system antagonism.